Dr Qiaoyun Wang is a Postdoctoral Research Fellow in the School of Chemistry at UNSW Sydney, working with Prof. Martina Stenzel. Her research lies at the interface of polymer chemistry, nanomedicine, and molecular imaging, focusing on the design of functional polymeric and hybrid nanomaterials (MOFs) for cancer therapy and diagnosis.
She completed her PhD at The University of Queensland (AIBN) under Prof. Andrew Whittaker, where she developed multifunctional MOF-based nanomaterials that combine therapeutic delivery and diagnostic imaging. Her current work integrates advanced imaging techniques such as 3D light-sheet microscopy, in vivo fluorescence imaging, and PET/MRI to study drug penetration, biodistribution, and tumour targeting of nanocarriers. She also collaborates with computational and immunometabolism experts to understand how nanomaterial design influences immune responses, metabolic regulation, and imaging-guided therapy outcomes.
Ultimately, her goal is to develop intelligent, image-guided nanocarriers that navigate complex biological environments to achieve precise drug delivery and real-time diagnostic imaging for improved cancer treatment outcomes.
Dr Qiaoyun Wang is a Postdoctoral Research Fellow in the School of Chemistry at UNSW Sydney, working with Prof. Martina Stenzel. Her research lies at the interface of polymer chemistry, nanomedicine, and molecular imaging, focusing on the design of functional polymeric and hybrid nanomaterials (MOFs) for cancer therapy and diagnosis.
She completed her PhD at The University of Queensland (AIBN) under Prof. Andrew Whittaker, where she developed multifunctional MOF-based nanomaterials that combine therapeutic delivery and diagnostic imaging. Her current work integrates advanced imaging techniques such as 3D light-sheet microscopy, in vivo fluorescence imaging, and PET/MRI to study drug penetration, biodistribution, and tumour targeting of nanocarriers. She also collaborates with computational and immunometabolism experts to understand how nanomaterial design influences immune responses, metabolic regulation, and imaging-guided therapy outcomes.
Ultimately, her goal is to develop intelligent, image-guided nanocarriers that navigate complex biological environments to achieve precise drug delivery and real-time diagnostic imaging for improved cancer treatment outcomes.